Department of Pulmonary and Critical Care Medicine, Peking University International Hospital, Beijing 102206, China
The article briefly introduces the development background, working principles and current trends of modern electronic cigarettes. E-cigarettes are born for tobacco control, but now there is growing evidence that e-cigarettes can cause lung damage.
The pathology, clinical features, diagnosis, treatment and prevention of e-cigarette or vaping product use associated lung injury (EVALI) are sorted and analyzed by sorting out domestic and foreign literature. The pathogenesis of EVALI is still unclear.
At this stage, the clinical diagnosis can only be made by analyzing the patient's history of using an e-cigarette, along with the results of imaging and laboratory tests. Patients should stop using e-cigarettes immediately after diagnosis and carry out corresponding treatment according to symptoms.
At the moment, the main treatment methods include supportive treatment, empirical antibiotic treatment, and early glucocorticoid treatment. Patients with respiratory distress or failure should be hospitalized for treatment.
Health and education departments around the world should promote the knowledge and harm of the use of vaping among the younger population, and reduce the harm caused by e-cigarettes to the public through policy restrictions on electronic cigarettes.
"Wishing all our valued partners, clients, and colleagues a Merry Christmas and a joyful holiday season from the VPLUS team! May the new year bring success, growth, and continued collaboration."
Dec 18, 2024
The lung’s delicate surfactant layer is of critical importance to the organ’s overall physiology and innate immune function. Both alveolar type II cells and alveolar macrophages are the principal subsets that maintain and catabolize surfactant at the liquid-air interface. Our study reveals that ENDS exposure disrupts both the lipid and protein components of pulmonary surfactant, […]
Dec 12, 2024
Neurodegenerative diseases leading to Parkinson's disease (PD) and Alzheimer's disease (AD) have become a major global health burden. Current treatments are mainly aimed at controlling symptoms, and there are no effective treatments in clinical practice to prevent neurodegeneration or induce neuronal repair. Therefore, the need for new research on these two diseases is urgent. The […]
Dec 05, 2024
Sativex® (nabiximols) is an oromucosal cannabinoid drug that contains 2.7 mg THC and 2.5 mg CBD per spray. It has been approved by regulators in 29 countries for the treatment of spasticity in multiple sclerosis. The medical application of cannabis began very early. From the mid-19th century to the 20th century, it was used by […]
Nov 26, 2024
Ultrasonic atomization uses ultrasonic directional pressure to make the liquid surface bulge, and cavitation occurs around the bulging liquid surface, causing the liquid to be atomized into small molecular mist. The oscillation frequency of the ultrasonic atomizer is 1.7MHz or 2.4MHz, which exceeds the human hearing range. The electronic oscillation is harmless to humans and […]
Nov 21, 2024